Paul Webster, MD
Pain Medicine · Kissimmee, FLNPI 1063470540
Payments from drug & device makers
Across 546 payments — averaging $33.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$4K
- Abbott$2K
- Spinal Simplicity, LLC$2K
- Nevro Corp.$1K
- Scilex Pharmaceuticals Inc.$553
- plus $4K from 33 others
What the payments were for
- Travel & lodging$3,37818%
- Food & beverage$14,61980%
- Entertainment$3312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 65 | $4,491 |
| Medtronic(3 entities) | 150 | $3,702 |
| Abbott | 54 | $2,239 |
| Spinal Simplicity, LLC | 33 | $2,154 |
| Nevro Corp. | 96 | $1,298 |
| Scilex Pharmaceuticals Inc. | 36 | $553 |
| Flowonix Medical Incorporated | 2 | $460 |
| Vertos Medical, Inc. | 5 | $318 |
| Saluda Medical Americas, Inc. | 4 | $315 |
| Protega Pharmaceutials Inc | 11 | $275 |
| Spinefrontier, Inc. | 2 | $267 |
| Biotronik NRO, Inc. | 11 | $265 |
| Surgentec | 1 | $249 |
| Nalu Medical, Inc. | 11 | $231 |
| AbbVie | 9 | $218 |
| Nutech Spine, Inc. | 1 | $194 |
| Supernus Pharmaceuticals, Inc. | 6 | $120 |
| Globus Medical | 4 | $119 |
| Amgen | 5 | $112 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| GRT US Holding, Inc. | 4 | $98 |
| Collegium Pharmaceutical, Inc. | 4 | $93 |
| Biodelivery Sciences International, Inc. | 4 | $73 |
| Daiichi Sankyo Inc. | 3 | $48 |
| Bioventus LLC | 2 | $45 |
| Painteq LLC | 2 | $37 |
| Novartis | 2 | $34 |
| SPR Therapeutics, Inc | 2 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Indivior Inc. | 1 | $22 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Orexo US, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
| Shionogi Inc | 1 | $15 |
| Stimwave Technologies Incorporated | 1 | $14 |
| Alkermes, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Superion Indirect Decompression System$2,276
- HA MINUTEMAN G3-R$1,247
- Prometra II$460
- INTELLIS ADAPTIVESTIM$430
- Proclaim Family of SCS IPGs$361
- INTELLIS$352
- mild Device Kit$257
- InSpan$237
- SIJFuse$237
- FacetFuse$237
- NanoFuse$237
- Evoke$231
- Senza Spinal Cord Stimulation System$121
- Proclaim IPG$119
- PROCLAIM$103
How this compares
$18,328 in reported general payments places this provider in the 85th percentile of 596 pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,086 | $66,845 |
| OxycontinOxycodone Hcl | 115 | $53,259 |
| Oxycodone Hcl | 2,241 | $52,394 |
| MovantikNaloxegol Oxalate | 94 | $41,770 |
| LinzessLinaclotide | 69 | $39,488 |
| Lidocaine | 559 | $37,950 |
| Xtampza ErOxycodone Myristate | 60 | $37,273 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,189 | $33,856 |
| Oxymorphone Hcl ErOxymorphone Hcl | 23 | $32,126 |
| Pregabalin | 896 | $27,001 |
| ZtlidoLidocaine | 64 | $23,784 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 110 | $19,312 |
| Gabapentin | 1,606 | $18,270 |
| Morphine Sulfate ErMorphine Sulfate | 867 | $17,409 |
| Aimovig AutoinjectorErenumab-Aooe | 24 | $16,885 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $93 | $47,82374 claims |
| Redhill Biopharma Inc.Movantik | $15 | $41,77094 claims |
| AbbVieLinzess | $218 | $39,48869 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $553 | $23,78464 claims |
| Indivior Inc.Suboxone | $22 | $12,70418 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 596 pain medicine providers in Florida.
Other pain medicine in Kissimmee
- Anand PatelOrmond Beach$20.4M
- Julio PaezClermont$2.3M
- Joseph PergolizziNaples$2.1M
- Abel MurilloMiami$1.6M
- George MonluxPalm Coast$1.3M
- Ferdinand FormosoJacksonville$1M
- Cesar LassalleOrlando$1M
- Robert GuirguisTampa$895K
- Ashraf HannaClearwater$608K
- Peter MichaelCoral Gables$496K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.